Electrolyte Syrup in pharma franchise in Rajasthan

Electrolyte Syrup in PCD pharma franchise in Chandigarh

Electrolyte Syrup in top pharma company in Rourkela

Electrolyte Syrup in pcd pharma supplier in Mangalore

Electrolyte Syrup in phama franchise company in India
Electrolyte Syrup in phama distributor in Dewas

Home/Products /potassium-citrate-1100mg-5ml-magnesium-citrate-375mg-5ml-vitamin-b6-pyridoxine-20mg-5ml-syrup

Uriviga B6 Syrup

Composition : Potassium Citrate (1100mg/5ml) + Magnesium Citrate (375mg/5ml) + Vitamin B6 (Pyridoxine) (20mg/5ml)

Dosage Form : Syrup

Packaging Type : with Carton

Packaging : 200 ml

Price : ₹210/-

Uriviga B6 Syrup is a specialized formulation aimed at promoting urinary health and preventing the recurrence of kidney stones. This syrup combines the therapeutic benefits of Potassium Citrate, Magnesium Citrate, and Vitamin B6 (Pyridoxine) to support kidney function and maintain a healthy urinary environment.

Potassium Citrate works by alkalizing the urine, reducing acidity levels, and minimizing the formation of uric acid and calcium oxalate stones. It enhances citrate levels in urine, which is a natural inhibitor of stone formation. Magnesium Citrate complements this by binding to oxalate, reducing its availability for kidney stone formation. Additionally, Vitamin B6 (Pyridoxine) decreases oxalate production in the body, further preventing stone formation while supporting overall metabolic health.

Uriviga B6 Syrup is especially effective for individuals prone to recurrent kidney stones and those diagnosed with conditions such as hypocitraturia (low urinary citrate levels). Its balanced composition helps improve urinary alkalinity and reduces the likelihood of future stone formation. The syrup form ensures ease of administration and better patient compliance, particularly for those who may have difficulty swallowing tablets.

Read More

About the Product

Uriviga B6 Syrup is a specialized formulation aimed at promoting urinary health and preventing the recurrence of kidney stones. This syrup combines the therapeutic benefits of Potassium Citrate, Magnesium Citrate, and Vitamin B6 (Pyridoxine) to support kidney function and maintain a healthy urinary environment.

Potassium Citrate works by alkalizing the urine, reducing acidity levels, and minimizing the formation of uric acid and calcium oxalate stones. It enhances citrate levels in urine, which is a natural inhibitor of stone formation. Magnesium Citrate complements this by binding to oxalate, reducing its availability for kidney stone formation. Additionally, Vitamin B6 (Pyridoxine) decreases oxalate production in the body, further preventing stone formation while supporting overall metabolic health.

Uriviga B6 Syrup is especially effective for individuals prone to recurrent kidney stones and those diagnosed with conditions such as hypocitraturia (low urinary citrate levels). Its balanced composition helps improve urinary alkalinity and reduces the likelihood of future stone formation. The syrup form ensures ease of administration and better patient compliance, particularly for those who may have difficulty swallowing tablets.

Potential side effects include mild gastrointestinal discomfort, nausea, or diarrhea. Rarely, allergic reactions may occur.

Uriviga B6 Syrup is indicated for the prevention of kidney stone formation, management of low urinary citrate levels, and maintenance of healthy urinary pH.

Use under medical supervision. Avoid exceeding the recommended dose. If symptoms persist or worsen, consult a healthcare professional promptly.

Store in a cool, dry place at temperatures below 30°C, away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation